颈动脉血运重建住院费用的变异性分析
该研究收集2013年9月至2015年8月单中心144例颈动脉内膜剥脱术(CEA)和颈动脉支架置入术(CAS)的住院费用数据,比较血管外科(VS)与其他科室(OSs)实施手术的费用差异。结果显示无症状CAS和无症状CEA中VS费用分别低17%和22%,症状性CEA中VS费用低14%,而CAS总体费用较CEA高38%。
要点
- 无症状患者平均住院费用较症状性患者低37%。
- 无症状CAS中VS费用较OSs低17%,主要因ICU、手术室、药物和心脏检查费用更低。
- 无症状CEA中VS费用较OSs低22%,症状性CEA中VS费用较OSs低14%。
核心结论
- VS在无症状CAS和所有CEA中的平均住院费用低于OSs。
- 费用差异可能源于医生实践差异和患者复杂性,可通过建立标准实践在适当时降低费用。
研究设计与样本
- 回顾性分析单中心2013年9月至2015年8月144例(78例无症状,66例有症状;44例CAS,100例CEA)接受单侧颈动脉血运重建患者的医院索赔数据,比较VS与OSs(神经外科和神经介入放射科)实施手术的费用。
主要发现
- VS与OSs的年龄(71±9岁 vs 70±11岁;P=.8)和住院时间(1.7±2.1天 vs 2.2±2.4天;P=.73)相似。
- 术前有症状者占46%,OSs更常治疗有症状患者(78% vs 29%;P<.001)。
- 按症状分层后病例组合指数相似(无症状:1.28±0.35 vs 1.39±0.42,P=.5;有症状:1.66±0.73 vs 1.82±0.81,P=.9)。
- 手术室相关费用、床位和耗材是最大费用构成,合计占76%。
- 无症状患者平均住院费用低37%;无症状CAS中VS费用低17%(ICU费用低78%、手术室相关费用低44%、药物费用低40%、心脏检查费用低24%,但耗材费用高22%);无症状CEA中VS费用低22%(手术室相关费用低28%、药物低28%、影像低62%、神经介入监测低64%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to understand drivers of cost for carotid endarterectomy (CEA) and carotid artery stenting (CAS) and to compare variation in cost among cases performed by vascular surgery (VS) with other services (OSs). METHODS: We collected internal hospital claims data for CEA and CAS between September 2013 and August 2015 and performed a financial analysis of all hospital costs including room accommodations, medications, medical and surgical supplies, imaging, and laboratory tests. Cases were stratified by presence of symptoms and procedure type, and costs of procedures performed by VS were compared with those performed by OSs. RESULTS: The cohort comprised 144 patients (78 asymptomatic, 66 symptomatic; 44 CAS, 100 CEA) receiving unilateral revascularization. VS (24 CAS, 70 CEA) and neurosurgery and neurointerventional radiology services (20 CAS, 30 CEA) performed all procedures. Age (71 ± 9 years vs 70 ± 11 years; P = .8) and length of stay (1.7 ± 2.1 days vs 2.2 ± 2.4 days; P = .73) were similar for VS and OSs. Symptoms were present before revascularization for 46% and were more commonly treated by OSs (78% vs 29%; P < .001). Case mix index was similar after stratifying by symptoms (asymptomatic, 1.28 ± 0.35 vs 1.39 ± 0.42 [P = .5]; symptomatic, 1.66 ± 0.73 vs 1.82 ± 0.81 [P = .9]). The largest cost components were operating room (OR)-related costs, beds, and supplies, together accounting for 76% of costs. Asymptomatic patients had 37% lower average hospital costs. For asymptomatic CAS, average index hospitalization cost was 17% less for VS compared with OSs because of 78% lower intensive care unit costs, 44% lower OR-related costs, 40% lower medication costs, and 24% lower cardiac testing costs. VS had 22% higher supply costs. For asymptomatic CEA, average index hospitalization costs were 22% lower for VS, driven by lower OR-related costs (28%), medications (28%), imaging (62%), and neurointerventional monitoring (64%). Costs were 38% higher for CAS vs CEA. For symptomatic CAS, costs were similar for both groups. For symptomatic CEA, total costs were 14% lower for VS compared with OSs, driven by 25% lower OR-related costs, 62% lower neurointerventional monitoring, 20% step-down beds, and 28% lower supply costs (and counterbalanced by 117% higher intensive care unit costs). CONCLUSIONS: VS average hospital costs were lower for asymptomatic CAS and all CEAs compared with OSs. Drivers of higher cost appear to be attributed to variation in physicians' practice as well as patients' complexity, affording an opportunity to reduce cost by establishing standard practices when appropriate.
引用
- Mell MW, Tang N, Lew R, et al. Variability in hospital costs for carotid artery revascularization. J Vasc Surg. 2018. PMID: 30197159. doi:10.1016/j.jvs.2018.05.228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。